Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
The global Ophthalmic Drugs market was valued at US$ 22440 million in 2019 and is expected to reach US$ 26300 million by the end of 2026, growing at a CAGR of 2.3% during 2021-2026.
This report focuses on Ophthalmic Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ophthalmic Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Ophthalmic Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Segment by Application
Hospital
Clinic
Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
The global Ophthalmic Drugs market was valued at US$ 22440 million in 2019 and is expected to reach US$ 26300 million by the end of 2026, growing at a CAGR of 2.3% during 2021-2026.
This report focuses on Ophthalmic Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ophthalmic Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Ophthalmic Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Segment by Application
Hospital
Clinic
Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
